Pascal Breton

958 total citations
38 papers, 776 citations indexed

About

Pascal Breton is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Pascal Breton has authored 38 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Biomaterials and 8 papers in Organic Chemistry. Recurrent topics in Pascal Breton's work include Nanoparticle-Based Drug Delivery (6 papers), Protein purification and stability (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Pascal Breton is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Protein purification and stability (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Pascal Breton collaborates with scholars based in France, United States and Switzerland. Pascal Breton's co-authors include Kenneth Olden, Jean‐Pierre Benoît, Catherine Passirani, Elvire Fournier, Patrick Couvreur, Pascale Garnier, F Petek, Françoise Goudey‐Perriere, Catherine Le Visage and Krzysztof Grzegorzewski and has published in prestigious journals such as Blood, Biomaterials and Cancer.

In The Last Decade

Pascal Breton

36 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Breton France 15 270 174 158 106 101 38 776
David T. Valenta United States 10 298 1.1× 36 0.2× 183 1.2× 161 1.5× 45 0.4× 14 876
Rebecca Lever United Kingdom 11 218 0.8× 77 0.4× 51 0.3× 108 1.0× 33 0.3× 19 688
Susanne Koling Germany 6 339 1.3× 45 0.3× 188 1.2× 48 0.5× 45 0.4× 8 692
G Zoppetti Italy 22 862 3.2× 271 1.6× 60 0.4× 166 1.6× 66 0.7× 52 1.6k
C D Black United States 15 475 1.8× 55 0.3× 104 0.7× 41 0.4× 36 0.4× 22 1.1k
Glen C. Todd United States 14 361 1.3× 71 0.4× 46 0.3× 116 1.1× 25 0.2× 24 1.0k
Atsushi Nagayasu Japan 13 300 1.1× 73 0.4× 294 1.9× 27 0.3× 101 1.0× 28 712
Cristina Monfardini United States 13 344 1.3× 128 0.7× 179 1.1× 17 0.2× 40 0.4× 19 757

Countries citing papers authored by Pascal Breton

Since Specialization
Citations

This map shows the geographic impact of Pascal Breton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Breton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Breton more than expected).

Fields of papers citing papers by Pascal Breton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Breton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Breton. The network helps show where Pascal Breton may publish in the future.

Co-authorship network of co-authors of Pascal Breton

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Breton. A scholar is included among the top collaborators of Pascal Breton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Breton. Pascal Breton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Renaudier, P., et al.. (2009). Complications pulmonaires de la transfusion (TACO–TRALI). Transfusion Clinique et Biologique. 16(2). 218–232. 18 indexed citations
2.
Renaudier, P., et al.. (2008). Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results. Transfusion Medicine and Hemotherapy. 35(2). 89–91. 6 indexed citations
3.
Breton, Pascal. (2007). Biocompatible poly(methylidene malonate)-made materials for pharmaceutical and biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics. 68(3). 479–495. 6 indexed citations
4.
Felt-Baeyens, O., Simone Eperon, Paolo Mora, et al.. (2006). Biodegradable scleral implants as new triamcinolone acetonide delivery systems. International Journal of Pharmaceutics. 322(1-2). 6–12. 31 indexed citations
5.
Eperon, Simone, et al.. (2005). Trans-Scleral Diffusion of Triamcinolone Acetonide. Current Eye Research. 30(5). 355–361. 19 indexed citations
6.
Beauvillain, Céline, Marie-Noëlle Mévélec, Philippe Roingeard, et al.. (2005). A novel CD4-CD8α+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis. Cellular Microbiology. 7(11). 1659–1671. 27 indexed citations
7.
Désiré, Laurent, et al.. (2005). Sustained delivery of growth factors from methylidene malonate 2.1.2-based polymers. Biomaterials. 27(12). 2609–2620. 11 indexed citations
8.
Fournier, Elvire, Catherine Passirani, Claudia N. Montero‐Menei, et al.. (2003). Therapeutic effectiveness of novel 5‐fluorouracil‐loaded poly(methylidene malonate 2.1.2)‐based microspheres on F98 glioma‐bearing rats. Cancer. 97(11). 2822–2829. 36 indexed citations
9.
Fournier, Elvire, et al.. (2003). Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers. European Journal of Pharmaceutics and Biopharmaceutics. 57(2). 189–197. 69 indexed citations
10.
Visage, Catherine Le, et al.. (2001). In vitroandin vivoEvaluation of Poly(Methylidene Malonate 2.1.2) Microparticles Behavior for Oral Administration. Journal of drug targeting. 9(2). 141–153. 11 indexed citations
11.
Visage, Catherine Le, Fabiana Quaglia, M. Dreux, et al.. (2001). Novel microparticulate system made of poly(methylidene malonate 2.1.2). Biomaterials. 22(16). 2229–2238. 17 indexed citations
12.
Salvador, Arnaud, et al.. (2000). Structure elucidation of methylidene malonate 2.1.2 cyclic trimers with mass spectrometry, liquid chromatography and nuclear magnetic resonance investigations. Journal of Pharmaceutical and Biomedical Analysis. 22(1). 165–174. 1 indexed citations
13.
George, Mariam, et al.. (1999). Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity. British Journal of Cancer. 80(1-2). 87–95. 34 indexed citations
14.
Velge-Roussel, Florence, et al.. (1996). Immunochemical characterization of antibody-coated nanoparticles. Cellular and Molecular Life Sciences. 52(8). 803–806. 11 indexed citations
15.
16.
Velge-Roussel, Florence, et al.. (1995). Analysis of human CD4-antibody interaction using the BIAcore system. Journal of Immunological Methods. 183(1). 141–148. 14 indexed citations
17.
Breton, Pascal, et al.. (1991). Production of macrophage-derived cytotoxic factor by N-[3-[(carbamoylmethyl)thio]propionylated] neoglycoproteins. Bioconjugate Chemistry. 2(1). 16–18. 6 indexed citations
18.
Olden, Kenneth, Pascal Breton, Krzysztof Grzegorzewski, et al.. (1991). The potential importance of swainsonine in therapy for cancers and immunology. Pharmacology & Therapeutics. 50(3). 285–290. 86 indexed citations
19.
Breton, Pascal, Michel Monsigny, & Roger Mayer. (1990). Ψ[CH2O] pseudodipeptide synthesis An improved approach which allows absolute configuration determination. International journal of peptide & protein research. 35(4). 346–351. 9 indexed citations
20.
Frébourg, Thierry, E Bercoff, J Sénant, et al.. (1988). The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer: A prospective study of 866 patients. Cancer. 62(11). 2287–2290. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David T. Valenta Breakdown of academic impact, for papers by Rebecca Lever Breakdown of academic impact, for papers by Susanne Koling Breakdown of academic impact, for papers by G Zoppetti Breakdown of academic impact, for papers by C D Black Breakdown of academic impact, for papers by Glen C. Todd Breakdown of academic impact, for papers by Atsushi Nagayasu Breakdown of academic impact, for papers by Cristina Monfardini
Rankless by CCL
2026